Cas no 1818-71-9 (Crotonoside)
Crotonoside Chemical and Physical Properties
Names and Identifiers
-
- 2-Hydroxyadenosine
- 1,2-dihydro-2-oxo-adenosin
- 1,2-dihydro-2-oxoadenosine
- 6-amino-9-beta-d-ribofuranosyl-9h-purin-2-o
- CROTONOSID
- 2-Hydroxydenosine
- 9-β-D-Ribofuranosylisoguanine
- Crotonoside
- Isoguanosine
- 2(1H)-Oxoadenosine
- 2-Oxo-1,2-dihydro-adenosin
- iso-Gr
- ISOGUANOSINE RIBOSIDE
- ISOGUANOSINE(P)
- 2,3-Dihydro-2-Oxo-Adenosine
- 9-(β-D-Ribofuranosyl)isoguanine
- Isoguanine Riboside
- Adenosine, 1,2-dihydro-2-oxo-
- Isoguanosine (7CI,8CI)
- Isoguanine, 9-beta-D-ribofuranosyl-
- 9H-Purin-2-ol, 6-amino-9-beta-D-ribofuranosyl-
- 6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1H-purin-2-one
- Isoguanosin
- isoguanineriboside
- Isoguanine, 9-.beta.-D-ribofuranosyl-
- Isoguanosine (VAN)
- 2-Oxo-3-hydroadenosine
- 2-Oxoado (isogua
- AS-59704
- BP-58626
- SCHEMBL2773634
- F12745
- BDBM82031
- 9H-PURIN-2-OL, 6-AMINO-9-.BETA.-D-RIBOFURANOSYL-(6C
- CCG-267276
- s9275
- NSC 12161
- 6V7FTE1Z1V
- Crotonoside, >=95% (HPLC)
- HY-N0071
- 6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3,9-dihydro-2H-purin-2-one
- NS00066984
- 2,3-DIHYDRO-2-OXOADENOSINE
- PDSP1_000998
- 6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-2-one
- NSC-12161
- CHEBI:3927
- CAS_1818-71-9
- CS-0007114
- CCRIS 8240
- UNII-6V7FTE1Z1V
- MFCD04971989
- (2R,3R,4S,5R)-2-(6-Amino-2-hydroxy-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
- H5F
- 6-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,9-dihydro-2H-purin-2-one
- 1818-71-9
- C08432
- MIKUYHXYGGJMLM-UUOKFMHZSA-N
- 9-(b-D-Ribofuranosyl)isoguanine
- 6-amino-9-((2S,3S,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-3H-purin-2(9H)-one;9-?-D-Ribofuranosylisoguanine
- AC-33996
- 6-azanyl-9-[(2R,3R,4S,5R)-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]-1H-purin-2-one
- PDSP2_000982
- AKOS015969770
- Q27106249
- 2-Oxoado (isoguanosine)
- CHEMBL1688963
- AKOS005445385
- SCHEMBL24615630
- NSC12161
- L000826
- Adenosine,2-dihydro-2-oxo-
- FT-0600136
- CHEMBL296017
- SCHEMBL23710581
- 38819-11-3
- 2-Hydroxyadenosine;Isoguanosine
- NCI60_000505
- 6-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-2-one
- SCHEMBL6683263
- BCP34471
- 6-Amino-9-pentofuranosyl-9H-purin-2-ol
- NCGC00168561-01
- Q15632739
- DTXSID70939474
- Oprea1_714106
- 2-Oxoadenosine
- 6-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-2-one
- Isoguanosine (VAN) (8CI)
- 9H-PURIN-2-OL, 6-AMINO-9-BETA-D-RIBOFURANOSYL-(6C
- DB-006158
- Adenosine, 2,3-dihydro-2-oxo-
-
- MDL： MFCD04971989
- Inchi： 1S/C10H13N5O5/c11-7-4-8(14-10(19)13-7)15(2-12-4)9-6(18)5(17)3(1-16)20-9/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,19)/t3-,5-,6-,9-/m1/s1
- InChI Key： MIKUYHXYGGJMLM-UUOKFMHZSA-N
- SMILES： O1[C@H](CO)[C@H]([C@H]([C@@H]1N1C=NC2=C(N)NC(N=C12)=O)O)O
Computed Properties
- Exact Mass: 283.09200
- Monoisotopic Mass: 283.09166853 g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 5
- Hydrogen Bond Acceptor Count: 7
- Heavy Atom Count: 20
- Rotatable Bond Count: 2
- Complexity: 544
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 4
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 153
- Molecular Weight: 283.24
- XLogP3: -3
Experimental Properties
- Color/Form: Powder
- Density: 2.3±0.1 g/cm3
- Boiling Point: 831℃/760mmHg
- PSA: 159.51000
- LogP: -2.10550
Crotonoside Security Information
- Signal Word：Warning
- Hazard Statement： H302-H315-H319
- Warning Statement： P261-P305+P351+P338
- Hazardous Material transportation number：NONH for all modes of transport
- WGK Germany：3
- Safety Instruction： 24/25
- Storage Condition：?20°C
Crotonoside Customs Data
- HS CODE：2934999090
- Customs Data：
China Customs Code:
2934999090Overview:
2934999090. Other heterocyclic compounds. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to
Summary:
2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Crotonoside Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| XI GE MA AO DE LI QI （ SHANG HAI ） MAO YI Co., Ltd. | SMB00322-5MG |
Crotonoside |
1818-71-9 | 5mg |
￥4180.69 | 2023-09-14 | ||
| XI GE MA AO DE LI QI （ SHANG HAI ） MAO YI Co., Ltd. | SMB00322-10MG |
Crotonoside |
1818-71-9 | ≥95% (HPLC) | 10MG |
￥5730.09 | 2022-02-22 | |
| abcr | AB462822-25 mg |
2-Hydroxyadenosine, 95%; . |
1818-71-9 | 95% | 25mg |
€219.90 | 2023-07-18 | |
| abcr | AB462822-100 mg |
2-Hydroxyadenosine, 95%; . |
1818-71-9 | 95% | 100MG |
€443.00 | 2023-07-18 | |
| Chengdu Biopurify Phytochemicals Ltd | BP0408-20mg |
Crotonoside |
1818-71-9 | 98% | 20mg |
$86 | 2023-09-20 | |
| Chengdu Biopurify Phytochemicals Ltd | BP0408-100mg |
Crotonoside |
1818-71-9 | 98% | 100mg |
$220 | 2023-09-20 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | X34925-5mg |
Crotonoside |
1818-71-9 | 95% | 5mg |
￥536.0 | 2024-07-18 | |
| ChemScence | CS-0007114-5mg |
Crotonoside |
1818-71-9 | 98.18% | 5mg |
$60.0 | 2021-09-02 | |
| ChemScence | CS-0007114-10mg |
Crotonoside |
1818-71-9 | 98.18% | 10mg |
$100.0 | 2021-09-02 | |
| ChemScence | CS-0007114-20mg |
Crotonoside |
1818-71-9 | 98.18% | 20mg |
$180.0 | 2021-09-02 |
Crotonoside Suppliers
Audited Supplier
Crotonoside Related Literature
-
Tingting Ding,Fan Tang,Guangcheng Ni,Jiang Liu,Hang Zhao,Qianming Chen RSC Adv. 2020 10 6223
-
2. Conversion of formycin into the fluorescent isoguanosine analogue 7-amino-3-(β-D-ribofuranosyl)-1H-pyrazolo[4,3-d]pyrimidin-5(4H)-oneSamarendra N. Bose,Shiv Kumar,R. Jeremy H. Davies,Satinder K. Sethi,James A. McCloskey J. Chem. Soc. Perkin Trans. 1 1984 2421
-
Valentina Abet,Rapha?l Rodriguez New J. Chem. 2014 38 5122
-
Naishka E. Caldero-Rodríguez,Carlos E. Crespo-Hernández Phys. Chem. Chem. Phys. 2022 24 6769
-
5. Improved synthesis of isoguanosine and 6-substituted xanthosine derivativesLorenzo De Napoli,Daniela Montesarchio,Gennaro Piccialli,Ciro Santacroce,Michela Varra J. Chem. Soc. Perkin Trans. 1 1995 15
Additional information on Crotonoside
Exploring Crotonoside (CAS No. 1818-71-9): A Comprehensive Guide to Its Properties and Applications
Crotonoside (CAS No. 1818-71-9) is a naturally occurring nucleoside derivative that has garnered significant attention in the fields of biochemistry and pharmacology. This compound, often referred to as a glycoside, is derived from the Croton plant species, which are known for their diverse medicinal properties. With the increasing interest in natural products and plant-derived compounds, Crotonoside has become a subject of extensive research due to its potential therapeutic benefits and unique chemical structure.
The chemical structure of Crotonoside features a ribose sugar moiety linked to a pyrimidine base, making it structurally similar to other nucleosides like uridine and cytidine. This similarity has led researchers to explore its role in nucleic acid metabolism and cellular signaling pathways. Recent studies have highlighted its potential as a bioactive compound, with applications ranging from anti-inflammatory agents to neuroprotective effects. The growing demand for natural alternatives in healthcare has further propelled interest in Crotonoside.
One of the most frequently asked questions about Crotonoside is its mechanism of action. Researchers have proposed that it may interact with enzyme systems involved in DNA replication and repair, although the exact pathways remain under investigation. Another hot topic is its potential role in cancer research, where preliminary studies suggest it could modulate cell proliferation and apoptosis. These findings align with the broader trend of exploring plant-based therapeutics for chronic diseases.
In addition to its pharmacological potential, Crotonoside is also studied for its biochemical properties. Its solubility in polar solvents and stability under various pH conditions make it a versatile compound for laboratory use. Scientists are particularly interested in its spectroscopic characteristics, such as its UV absorption profile, which aids in its identification and quantification. These properties are crucial for developing analytical methods to study Crotonoside in complex biological matrices.
The safety profile of Crotonoside is another area of interest. While it is generally considered safe for research purposes, ongoing studies aim to evaluate its toxicity and bioavailability in different organisms. This aligns with the increasing consumer demand for evidence-based information on natural compounds. As more data becomes available, Crotonoside could find applications in nutraceuticals and functional foods, catering to the growing market for health-enhancing ingredients.
From an industrial perspective, the extraction and purification of Crotonoside present both challenges and opportunities. Advanced techniques like chromatography and crystallization are often employed to isolate this compound from plant sources. The scalability of these methods is a key consideration for commercial production, especially given the rising demand for high-purity natural products. Researchers are also exploring synthetic routes to produce Crotonoside, which could offer a more sustainable and cost-effective alternative.
In conclusion, Crotonoside (CAS No. 1818-71-9) represents a fascinating intersection of natural product chemistry and biomedical research. Its unique properties and potential applications make it a compound worth watching in the coming years. Whether you're a researcher, a healthcare professional, or simply curious about plant-derived compounds, understanding Crotonoside can provide valuable insights into the future of natural therapeutics and biochemical innovation.
1818-71-9 (Crotonoside) Related Products
- 64283-15-4(2H-Purin-2-one,6-amino-9-b-D-glucopyranosyl-1,9-dihydro-(9CI))
- 106449-56-3(2’-Deoxyisoguanosine)
- 140156-26-9(Adenosine,1,2-dihydro-2-oxo-1-(1-propenyl)-, (Z)- (9CI))
- 359436-55-8(ISOGUANOSINE HYDRATE)
- 133966-97-9(Adenosine, 1,2-dihydro-2-oxo-1-(2-propenyl)-)
- 133502-23-5(Adenosine, N-cyclopentyl-1,2-dihydro-2-oxo-)
- 73691-64-2(Adenosine, 1-ethyl-1,2-dihydro-2-oxo-)
- 23605-76-7(Adenosine,2,3-dihydro-N-methyl-2-oxo-)
- 133967-00-7(Adenosine,1-cyclopropyl-1,2-dihydro-2-oxo- (9CI))
- 173098-06-1(Isoguanosine Triacetate)
